Targeting huntingtin expression in patients with Huntington’s disease SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ... New England Journal of Medicine 380 (24), 2307-2316, 2019 | 706 | 2019 |
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment V Roessner, KJ Plessen, A Rothenberger, AG Ludolph, R Rizzo, L Skov, ... European child & adolescent psychiatry 20, 173-196, 2011 | 550 | 2011 |
The cognitive impact of antiepileptic drugs CM Eddy, HE Rickards, AE Cavanna Therapeutic advances in neurological disorders 4 (6), 385-407, 2011 | 448 | 2011 |
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 445 | 2012 |
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017 | 320 | 2017 |
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY) E van Duijn, D Craufurd, AAM Hubers, EJ Giltay, R Bonelli, H Rickards, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (12), 1411-1418, 2014 | 319 | 2014 |
Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke H Rickards Journal of Neurology, Neurosurgery & Psychiatry 76 (suppl 1), i48-i52, 2005 | 274 | 2005 |
Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome M Porta, A Brambilla, AE Cavanna, D Servello, M Sassi, H Rickards, ... Neurology 73 (17), 1375-1380, 2009 | 208 | 2009 |
Treatment strategies for tics in Tourette syndrome CM Eddy, HE Rickards, AE Cavanna Therapeutic Advances in Neurological Disorders 4 (1), 25-45, 2011 | 165 | 2011 |
Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations J Piedad, H Rickards, FMC Besag, AE Cavanna CNS drugs 26, 319-335, 2012 | 153 | 2012 |
A pilot study using nabilone for symptomatic treatment in Huntington's disease A Curtis, I Mitchell, S Patel, N Ives, H Rickards Movement disorders: official journal of the Movement Disorder Society 24 (15 …, 2009 | 152 | 2009 |
Therapies for depression in Parkinson's disease S Ghazi‐Noori, TH Chung, K Deane, HE Rickards, CE Clarke, ... Cochrane Database of Systematic Reviews 2010 (1), 1996 | 150 | 1996 |
Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and … C Hollis, M Pennant, J Cuenca, C Glazebrook, T Kendall, C Whittington, ... NIHR Journals Library, 2016 | 149 | 2016 |
Time to end the distinction between mental and neurological illnesses PD White, H Rickards, AZJ Zeman Bmj 344, 2012 | 144 | 2012 |
The psychopathological spectrum of Gilles de la Tourette syndrome AE Cavanna, H Rickards Neuroscience & Biobehavioral Reviews 37 (6), 1008-1015, 2013 | 141 | 2013 |
Cannabinoids for Tourette's syndrome A Curtis, CE Clarke, HE Rickards Cochrane Database of Systematic Reviews, 2009 | 133 | 2009 |
Prognosis and outcome predictors in psychogenic nonepileptic seizures J Durrant, H Rickards, AE Cavanna Epilepsy research and treatment 2011 (1), 274736, 2011 | 130 | 2011 |
Impulse-control disorders in gilles de la tourette syndrome A Wright, H Rickards, AE Cavanna The Journal of neuropsychiatry and clinical neurosciences 24 (1), 16-27, 2012 | 113 | 2012 |
Proprioceptive sensory function in Parkinson's disease and Huntington's disease: evidence from proprioception-related EEG potentials E Seiss, P Praamstra, C Hesse, H Rickards Experimental brain research 148, 308-319, 2003 | 113 | 2003 |
Changes in mental state and behaviour in Huntington's disease CM Eddy, EG Parkinson, HE Rickards The Lancet Psychiatry 3 (11), 1079-1086, 2016 | 110 | 2016 |